Day one of #ESCCongress highlighted the remarkable pace of progress in CV medicine. From emerging therapies to innovative trial designs, the focus remains on generating high-quality evidence and getting it into practice faster. #ESC26
@bradleymaronmd
@HeartDocSadiya
@MCarnethon